A potential 5-HT1A receptor antagonist: p-MPPI.
A potential 5-HT1A receptor antagonist: p-MPPI.
复制标题
DOI:
10.1016/0024-3205(94)00686-5
复制
发表时间:
1994
期刊:
影响因子:
6.1
通讯作者:
H. Kung;M. Kung;W. Clarke;S. Maayani;Z. Zhuang
中科院分区:
文献类型:
--
作者:
H. Kung;M. Kung;W. Clarke;S. Maayani;Z. Zhuang
A potential 5-HT1Areceptor antagonist, p-MPPI, 4-(2'-methoxy-)phenyl-1-[2'-(n-2“-pyridinyl)-p-iodobenzamido-] ethyl-piperazine, was developed. The [125I]p-MPPI demonstrated high affinity and selectivity toward 5-HT1Areceptors: Kd= 0.36 nM and Bmax= 264 fmol/mg of protein in rat hippocampal membrane homogenates. The binding is not sensitive to GTP (300μM) or Gpp(NH)p (100 μM). In forskolin-stimulated adenylyl cyclase assay using rat hippocampus, p-MPPI (up to 10 μM) showed no agonist activity as compared to that of (±)-8-OH-DPAT. At 100 nM it completely antagonized the inhibition of forskolin-stimulated adenylyl cyclase activity produced by 100 nM of (±)-8-OH-DPAT. This potential 5-HT1Aantagonist may provide a powerful tool for studies of the pharmacology of the 5-HT1Areceptor system.